Mast cell renin and a local renin-angiotensin system in the airway: Role in bronchoconstriction

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 4, 2008, Pages 1315-1320

  Veerappan, Arul ^a   Reid, Alicia C ^a   Estephan, Racha ^a   O'Connor, Nathan ^a   Thadani Mulero, Maria ^a   Salazar Rodriguez, Mariselis ^a   Levi, Roberto ^a   Silver, Randi B ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Angiotensin II; Angiotensin II type 1 receptors; Asthma; Hypersensitivity; Lung

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN I; ANGIOTENSIN II; BETA N ACETYLHEXOSAMINIDASE; BILA 2157; HISTAMINE; RENIN; RENIN INHIBITOR; RNA; UNCLASSIFIED DRUG;

AIRWAY; ANAPHYLAXIS; ANIMAL CELL; ANIMAL TISSUE; BRONCHOSPASM; CELL ISOLATION; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME RELEASE; EXON; GUINEA PIG; HYPERSENSITIVITY; LUNG PARENCHYMA; LUNG PERFUSION; MAST CELL; MAST CELL DEGRANULATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENIN RELEASE; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SMOOTH MUSCLE CONTRACTION; ANIMAL; ARTICLE; BIOSYNTHESIS; BRONCHUS; CHEMISTRY; CYTOLOGY; DEGRANULATION; ENZYMOLOGY; GENETICS; HUMAN; LUNG; MALE; METABOLISM; MUSCLE CONTRACTION; PHYSIOLOGY; SECRETION; SMOOTH MUSCLE; SPRAGUE DAWLEY RAT;

CAVIA; RATTUS;

ANGIOTENSIN II; ANIMALS; BRONCHI; BRONCHOCONSTRICTION; CELL DEGRANULATION; GUINEA PIGS; HUMANS; LUNG; MALE; MAST CELLS; MUSCLE CONTRACTION; MUSCLE, SMOOTH; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN; RENIN-ANGIOTENSIN SYSTEM;

EID: 39549119564     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0709739105     Document Type: Article

References (43)

1. Valtin H, Schafer JA (1995) in Renal Function (Little, Brown, Boston), pp 135-138.
2. Phillips MI, Speakman EA, Kimura B (1993) Regul Pept 43:1-20.
3. Marshall RP, Gohlke P, Chambers RC, Howell DC, Bottoms SE, Unger T, McAnulty RJ, Laurent GJ (2004) Am J Physiol 286:L156-L164.
4. Campbell DJ, Kladis A, Duncan AM (1993) Hypertension 22:513-522.
5. Campbell DJ, Kladis A, Valentijn AJ (1995) J Cardiovasc Pharmacol 26:233-240.
6. Campbell DJ, Habener JF (1986) J Clin Invest 78:31-39.
7. Campbell DJ, Habener JF (1989) Endocrinology 124:218-222.
8. Vane JR (1969) Br J Pharmacol 35:209-242.
9. Paxton WG, Runge M, Horaist C, Cohen C, Alexander RW, Bernstein KE (1993) Am J Physiol 264:F989-F995.
10. Bullock GR, Steyaert I, Bilbe G, Carey RM, Kips J, De Paepe B, Pauwels R, Praet M, Siragy HM, de Gasparo M (2001) Histochem Cell Biol 115:117-124.
11. Silver RB, Reid AC, Mackins CJ, Askwith T, Schaefer U, Herzlinger D, Levi R (2004) Proc Natl Acad Sci USA 101:13607-13612.
12. Mackins CJ, Kano S, Seyedi N, Schafer U, Reid AC, Machida T, Silver RB, Levi R (2006) J Clin Invest 116:1063-1070.
13. Boyce JA (2003) Prostaglandins Leukot Essent Fatty Acids 69:195-205.
14. Millar EA, Angus RM, Hulks G, Morton JJ, Connell JM, Thomson NC (1994) Thorax 49:492-495.
15. Simoneau B, Lavallee P, Anderson PC, Bailey M, Bantle G, Berthiaume S, Chabot C, Fazal G, Halmos T, Ogilvie WW, et al. (1999) Bioorg Med Chem 7:489-508.
16. Wong PC, Price WA, Jr., Chiu AT, Duncia JV, Carini DJ, Wexler RR, Johnson AL, Timmermans PB (1990) J Pharmacol Exp Ther 255:211-217.
17. Hargreave FE, Ryan, G, Thomson NC, O'Byrne PM, Latimer K, Juniper EF (1982) Eur J Respir Dis Suppl 121:79-88.
18. Ward MD, Selgrade MK (2007) Methods 41:80-90.
19. Chand N, Eyre P (1978) Agents Actions 8:171-184.
20. Lulich KM, Paterson JW (1980) Br J Pharmacol 68:633-636.
21. Tharp MD, Seelig LL, Jr., Tigelaar RE, Bergstresser PR (1985) J Histochem Cytochem 33:27-32.
22. Kokkonen JO, Kovanen PT (1987) Biochem J 241:583-589.
23. Campbell WG, Gahnem F, Catanzaro DF, James GD, Camargo MJ, Laragh JH, Sealey JE (1996) Hypertension 27:1121-1133.
24. Levi R, Capurro N, Lee CH (1975) Eur J Pharmacol 30:328-335.
25. Chand N, DeRoth L (1979) Pharmacology 19:185-190.
26. Capurro N, Levi R (1975) Circ Res 36:520-528.
27. Lewis A, Blumenthal A, Dervinis A (1983) Inflamm Res 13:269-275.
28. Becker BN, Jacobson LM, Becker YT, Radke NA, Heisey DM, Oberley TD, Pirsch JD, Sollinger HW, Brazy PC, Kirk AD (2000) Transplantation 69:1485-1491.
29. Hackenthal E, Hackenthal R, Hilgenfeldt U (1978) Biochim Biophys Acta 522:574-588.
30. Hirsch AT, Pinto YM, Schunkert H, Dzau VJ (1990) Am J Cardiol 66:22D-30D.
31. Unger T, Badoer E, Ganten D, Lang RE, Rettig R (1988) Circulation 77:140-154.
32. Wagner J, Jan Danser AH, Derkx FH, de Jong TV, Paul M, Mullins JJ, Schalekamp MA, Ganten D (1996) Br J Ophthalmol 80:159-163.
33. Laitinen LA, Laitinen A, Haahtela T (1993) Am Rev Respir Dis 147:697-704.
34. Brightling CE, Bradding P, Symon FA, Holgate ST, Wardlaw AJ, Pavord ID (2002) N Engl J Med 346:1699-1705.
35. Millar EA, Nally JE, Thomson NC (1995) Eur Respir J 8:1838-1841.
36. Ramsay SG, Clayton RA, Dagg KD, Thomson LJ, Nally JE, Thomson NC (1997) Respir Med 91:609-615.
37. Galli SJ, Gordon JR, Wershil BK (1993) Agents Actions Suppl 43:209-220.
38. Galli SJ (1993) N Engl J Med 328:257-265.
39. Luft FC (2001) Curr Hypertens Rep 3:61-67.
40. Ikawati Z, Hayashi M, Nose M, Maeyama K (2000) Eur J Pharmacol 402:297-306.
41. Feigen GA, Prager DJ (1969) Am J Cardiol 24:474-491.
42. Levi R (1988) in Human Inflammatory Disease, Clinical Immunology, eds Marone G, Lichtenstein LM, Condorelli M, Fauci AS (B. C. Decker, Toronto), pp 93-105.
43. Schwartz LB, Austen KF, Wasserman SI (1979) J Immunol 123:1445-1450.